Cargando…
Mesenchymal stem cells ameliorate β cell dysfunction of human type 2 diabetic islets by reversing β cell dedifferentiation
BACKGROUND: A physiological hallmark of patients with type 2 diabetes mellitus (T2DM) is β cell dysfunction. Despite adequate treatment, it is an irreversible process that follows disease progression. Therefore, the development of novel therapies that restore β cell function is of utmost importance....
Autores principales: | Wang, Le, Liu, Tengli, Liang, Rui, Wang, Guanqiao, Liu, Yaojuan, Zou, Jiaqi, Liu, Na, Zhang, Boya, Liu, Yan, Ding, Xuejie, Cai, Xiangheng, Wang, Zhiping, Xu, Xiumin, Ricordi, Camillo, Wang, Shusen, Shen, Zhongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000334/ https://www.ncbi.nlm.nih.gov/pubmed/31918404 http://dx.doi.org/10.1016/j.ebiom.2019.102615 |
Ejemplares similares
-
Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes
por: Liu, Tengli, et al.
Publicado: (2021) -
Adipose Tissue-Derived Stem Cells from Type 2 Diabetics Reveal Conservative Alterations in Multidimensional Characteristics
por: Wang, Le, et al.
Publicado: (2020) -
Characteristics of research-focused human islet preparations from organ donors with type 2 diabetes
por: Liang, Rui, et al.
Publicado: (2023) -
The inhibition of FKBP5 protects β-cell survival under inflammation stress via AKT/FOXO1 signaling
por: Liu, Na, et al.
Publicado: (2023) -
Single-cell transcriptomics of human islet ontogeny defines the molecular basis of β-cell dedifferentiation in T2D
por: Avrahami, Dana, et al.
Publicado: (2020)